The monoclonal antibody dupilumab (Dupixent) led to significant improvements in esophageal distensibility among patients with eosinophilic esophagitis, the randomized REMODEL trial showed. At 24 weeks ...
Efficacy and safety of nivolumab and docetaxel combination therapy versus nivolumab monotherapy for the treatment of advanced non-small cell lung cancer: A systematic review and meta-analysis. This is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results